KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Shares Issued (2016 - 2025)

Teladoc Health's Shares Issued history spans 12 years, with the latest figure at $4000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 99.53% year-over-year to $4000.0; the TTM value through Dec 2025 reached $85000.0, down 97.62%, while the annual FY2025 figure was $85000.0, 97.62% down from the prior year.
  • Shares Issued for Q4 2025 was $4000.0 at Teladoc Health, up from -$1.3 million in the prior quarter.
  • Across five years, Shares Issued topped out at $11.8 million in Q4 2021 and bottomed at -$1.7 million in Q2 2022.
  • The 5-year median for Shares Issued is $1.1 million (2024), against an average of $2.3 million.
  • The largest annual shift saw Shares Issued soared 600.0% in 2024 before it tumbled 1397.7% in 2025.
  • A 5-year view of Shares Issued shows it stood at $11.8 million in 2021, then crashed by 73.57% to $3.1 million in 2022, then surged by 164.14% to $8.2 million in 2023, then tumbled by 89.61% to $855000.0 in 2024, then tumbled by 99.53% to $4000.0 in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Shares Issued are $4000.0 (Q4 2025), -$1.3 million (Q3 2025), and $1.3 million (Q2 2025).